The US Securities and Exchange Commission (SEC) on Tuesday charged Florida-based drugmaker TherapeuticsMD with violating fair disclosure regulations by selectively sharing nonpublic information from interactions with the US Food and Drug Administration (FDA) with sell-side analysts.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,